Mesoblast Limited (MESO)
NASDAQ: MESO
· Real-Time Price · USD
11.75
-0.41 (-3.37%)
At close: Jun 13, 2025, 3:59 PM
11.78
0.26%
After-hours: Jun 13, 2025, 04:04 PM EDT
Revenue by Geography
| Period Ending | Jun 30, 2020 |
|---|---|
| Australia Revenue | 20M |
| Australia Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8.59M | 8.59M | 6.07M | 6.07M | 5.74M | 5.74M | 14.41M | 12.65M | 14.28M | 11.76M | 16.99M | 13.16M | 14.4M | 13.41M | 14.25M | 15.42M | 14.32M | 19.6M | 17.5M | 13.34M | 11.91M | 8.16M | 8.07M | 8.45M | 10.53M | 9.93M | 7.34M | 7.74M | 6.44M | 5.89M | 8.3M | 9.35M | 8.67M | 8.75M | 13.55M | 13.13M | 13.83M | 11.74M | 27.4M | 12.04M |
| Selling, General, and Administrative Revenue Growth | 0.00% | +41.53% | 0.00% | +5.77% | 0.00% | -60.17% | +13.91% | -11.39% | +21.39% | -30.76% | +29.14% | -8.66% | +7.37% | -5.84% | -7.60% | +7.70% | -26.97% | +12.01% | +31.18% | +12.01% | +45.95% | +1.07% | -4.43% | -19.74% | +6.00% | +35.30% | -5.19% | +20.14% | +9.42% | -29.03% | -11.26% | +7.87% | -0.97% | -35.42% | +3.21% | -5.06% | +17.86% | -57.16% | +127.57% | n/a |
| Research and Development Revenue | 10.32M | 10.32M | 6.35M | 6.35M | 6.32M | 6.32M | 6.69M | 7.07M | 7.68M | 5.74M | 5.04M | 8.25M | 10.2M | 9.33M | 7.05M | 12.44M | 14.24M | 19.28M | 15.27M | 14.38M | 14.15M | 12.39M | 11.44M | 14.41M | 15.49M | 18.49M | 17.54M | 16.8M | 16.22M | 15.37M | 15.94M | 13.93M | 15.04M | 14M | 14.39M | 12.02M | 12.52M | 11.09M | 33.42M | 13.44M |
| Research and Development Revenue Growth | 0.00% | +62.51% | 0.00% | +0.47% | 0.00% | -5.52% | -5.28% | -8.03% | +33.76% | +13.99% | -38.92% | -19.10% | +9.33% | +32.22% | -43.29% | -12.62% | -26.14% | +26.28% | +6.17% | +1.59% | +14.25% | +8.34% | -20.63% | -6.98% | -16.23% | +5.42% | +4.41% | +3.55% | +5.56% | -3.58% | +14.44% | -7.41% | +7.42% | -2.72% | +19.81% | -4.00% | +12.86% | -66.82% | +148.62% | n/a |